Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Teladoc Health, Inc.TDOC · Entity 1547 | CHIEF MARKETING OFFICER | August 30, 2024 | September 04, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Teladoc Health, Inc.
Report date August 30, 2024 · Filed September 04, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 48,843 |
Ending reported balance
After 2024-09-03 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2024-08-30 · Exercise / conversion · Acquired 1,109 · Balance 46,267 F1: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Row 2 · 2024-08-30 · Exercise / conversion · Acquired 1,404 · Balance 47,671 F2: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Row 3 · 2024-08-30 · Exercise / conversion · Acquired 3,255 · Balance 50,926 F2: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Row 4 · 2024-09-03 · Sale · Disposed 2,083 · Balance 48,843 F3: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. |
| Performance Stock UnitsSEC Table II · derivative / convertible security | Direct | 6,658 |
Reported balance
After 2024-08-30 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2024-08-30 · Exercise / conversion · Disposed 1,109 · Balance 6,658 F1: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F4: The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 2,808 |
Reported balance
After 2024-08-30 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2024-08-30 · Exercise / conversion · Disposed 1,404 · Balance 2,808 F2: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F5: On March 1, 2022, the reporting person was granted 16,844 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 19,532 |
Reported balance
After 2024-08-30 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2024-08-30 · Exercise / conversion · Disposed 3,255 · Balance 19,532 F2: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F6: On March 3, 2023, the reporting person was granted 39,063 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
F2: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F3: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
F4: The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F5: On March 1, 2022, the reporting person was granted 16,844 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F6: On March 3, 2023, the reporting person was granted 39,063 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 02, 2023 Filed Mar 3, 2023 16:15 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,147 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-23-004096 · form4-03032023_090316.xml · nonDerivative · entry 6 Verstraete Stephany · CIK 0001726419 · CHIEF MARKETING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,986 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 16:15 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 772 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-23-004096 · form4-03032023_090316.xml · nonDerivative · entry 5 Verstraete Stephany · CIK 0001726419 · CHIEF MARKETING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,839 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 16:15 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 3,072 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-23-004096 · form4-03032023_090316.xml · nonDerivative · entry 4 Verstraete Stephany · CIK 0001726419 · CHIEF MARKETING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,067 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 16:15 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,807 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-23-004096 · form4-03032023_090316.xml · nonDerivative · entry 3 Verstraete Stephany · CIK 0001726419 · CHIEF MARKETING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,995 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 16:15 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 2,254 | $25.36 | $57,165.95 |
DisclosureSEC source: 0001415889-23-004096 · form4-03032023_090316.xml · nonDerivative · entry 2 Verstraete Stephany · CIK 0001726419 · CHIEF MARKETING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,188 F2 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 16:15 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 5,614 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-004096 · form4-03032023_090316.xml · derivative · entry 9 Verstraete Stephany · CIK 0001726419 · CHIEF MARKETING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,230 Underlying: Common Stock · 5,614 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F4 · derivative.exercise_date: On March 1, 2022, the reporting person was granted 16,844 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F4 · derivative.expiration_date: On March 1, 2022, the reporting person was granted 16,844 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 16:15 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 5,614 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-23-004096 · form4-03032023_090316.xml · nonDerivative · entry 1 Verstraete Stephany · CIK 0001726419 · CHIEF MARKETING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,442 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 16:18 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantEmployee Stock Option (right to buy) · Derivative | 58,782 | $0.00 Strike: $32.62 | $0.00 |
DisclosureSEC source: 0001415889-22-006095 · form4-06032022_010645.xml · derivative · entry 1 Verstraete Stephany · CIK 0001726419 · CHIEF MARKETING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,782 Underlying: Common Stock · 58,782 shares Expires 2032-05-31 F1 · derivative.exercise_date: The option will vest as to one-third of the shares on June 1, 2023. The remainder of the shares will vest in 24 substantially equal monthly installments thereafter. Read SEC document |
| March 07, 2022 Filed Mar 8, 2022 16:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 3,774 | $66.74 | $251,865.44 |
DisclosureSEC source: 0001179110-22-002055 · edgar.xml · nonDerivative · entry 3 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,828 F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit and performance stock unit awards. Read SEC document |
| March 04, 2022 Filed Mar 8, 2022 16:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 4,811 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-002055 · edgar.xml · derivative · entry 5 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,811 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F5 · derivative.exercise_date: On February 26, 2020, the reporting person earned 14,433 performance stock units, vesting in three substantially equal annual installments beginning on March 4, 2020. F5 · derivative.expiration_date: On February 26, 2020, the reporting person earned 14,433 performance stock units, vesting in three substantially equal annual installments beginning on March 4, 2020. Read SEC document |
| March 04, 2022 Filed Mar 8, 2022 16:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 3,701 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-002055 · edgar.xml · derivative · entry 4 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,701 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F4 · derivative.exercise_date: On March 4, 2019, the reporting person was granted 11,103 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. F4 · derivative.expiration_date: On March 4, 2019, the reporting person was granted 11,103 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| March 04, 2022 Filed Mar 8, 2022 16:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 4,811 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-22-002055 · edgar.xml · nonDerivative · entry 2 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,602 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 04, 2022 Filed Mar 8, 2022 16:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 3,701 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-22-002055 · edgar.xml · nonDerivative · entry 1 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,791 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 03, 2022 Filed Mar 4, 2022 18:46 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 2,858 | $70.24 | $200,743.06 |
DisclosureSEC source: 0001415889-22-002589 · form4-03042022_030338.xml · nonDerivative · entry 6 Verstraete Stephany · CIK 0001726419 · CHIEF MARKETING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,090 F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit and performance stock unit awards. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 18:46 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 868 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-002589 · form4-03042022_030338.xml · derivative · entry 13 Verstraete Stephany · CIK 0001726419 · CHIEF MARKETING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,734 Underlying: Common Stock · 868 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F13 · derivative.exercise_date: On March 2, 2022, the reporting person earned 2,602 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2022. F13 · derivative.expiration_date: On March 2, 2022, the reporting person earned 2,602 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2022. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 18:46 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantPerformance Stock Units · Derivative | 2,602 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-002589 · form4-03042022_030338.xml · derivative · entry 12 Verstraete Stephany · CIK 0001726419 · CHIEF MARKETING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,602 Underlying: Common Stock · 2,602 shares Expires not disclosed F6 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of TDOC common stock. F11 · shares: Performance award amount determined based on metrics in respect of the issuer's 2021 financial results. F12 · derivative.exercise_date: The performance stock units vest in three substantially equal annual installments beginning on March 2, 2022. F12 · derivative.expiration_date: The performance stock units vest in three substantially equal annual installments beginning on March 2, 2022. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 18:46 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 1,147 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-002589 · form4-03042022_030338.xml · derivative · entry 11 Verstraete Stephany · CIK 0001726419 · CHIEF MARKETING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,295 Underlying: Common Stock · 1,147 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F10 · derivative.exercise_date: On March 2, 2021, the reporting person was granted 3,442 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. F10 · derivative.expiration_date: On March 2, 2021, the reporting person was granted 3,442 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 18:46 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 773 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-002589 · form4-03042022_030338.xml · derivative · entry 10 Verstraete Stephany · CIK 0001726419 · CHIEF MARKETING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 772 Underlying: Common Stock · 773 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F9 · derivative.exercise_date: On March 2, 2022, the reporting person earned 1,545 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2022. F9 · derivative.expiration_date: On March 2, 2022, the reporting person earned 1,545 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2022. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 18:46 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantPerformance Stock Units · Derivative | 1,545 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-002589 · form4-03042022_030338.xml · derivative · entry 9 Verstraete Stephany · CIK 0001726419 · CHIEF MARKETING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,545 Underlying: Common Stock · 1,545 shares Expires not disclosed F6 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of TDOC common stock. F7 · shares: Performance award amount determined based on metrics in respect of the issuer's financial results over a two-year performance period ending in 2021. F8 · derivative.exercise_date: The performance stock units vest in two substantially equal annual installments beginning on March 2, 2022. F8 · derivative.expiration_date: The performance stock units vest in two substantially equal annual installments beginning on March 2, 2022. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 18:46 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 3,074 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-002589 · form4-03042022_030338.xml · derivative · entry 8 Verstraete Stephany · CIK 0001726419 · CHIEF MARKETING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,072 Underlying: Common Stock · 3,074 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F5 · derivative.exercise_date: On March 2, 2021, the reporting person earned 9,218 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2021. F5 · derivative.expiration_date: On March 2, 2021, the reporting person earned 9,218 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2021. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 18:46 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 1,808 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-002589 · form4-03042022_030338.xml · derivative · entry 7 Verstraete Stephany · CIK 0001726419 · CHIEF MARKETING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,807 Underlying: Common Stock · 1,808 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F4 · derivative.exercise_date: On March 2, 2020, the reporting person was granted 5,422 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. F4 · derivative.expiration_date: On March 2, 2020, the reporting person was granted 5,422 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 18:46 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 868 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-22-002589 · form4-03042022_030338.xml · nonDerivative · entry 5 Verstraete Stephany · CIK 0001726419 · CHIEF MARKETING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,948 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 18:46 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,147 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-22-002589 · form4-03042022_030338.xml · nonDerivative · entry 4 Verstraete Stephany · CIK 0001726419 · CHIEF MARKETING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,080 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 18:46 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 773 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-22-002589 · form4-03042022_030338.xml · nonDerivative · entry 3 Verstraete Stephany · CIK 0001726419 · CHIEF MARKETING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,933 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 18:46 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 3,074 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-22-002589 · form4-03042022_030338.xml · nonDerivative · entry 2 Verstraete Stephany · CIK 0001726419 · CHIEF MARKETING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,160 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 18:46 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,808 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-22-002589 · form4-03042022_030338.xml · nonDerivative · entry 1 Verstraete Stephany · CIK 0001726419 · CHIEF MARKETING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,086 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 16:42 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 16,844 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-001920 · edgar.xml · derivative · entry 1 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,844 Underlying: Common Stock · 16,844 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F2 · derivative.exercise_date: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F2 · derivative.expiration_date: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| November 03, 2021 Filed Nov 4, 2021 16:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,000 | $0.00 Strike: $38.55 | $0.00 |
DisclosureSEC source: 0001179110-21-009878 · edgar.xml · derivative · entry 3 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,331 Underlying: Common Stock · 1,000 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on August 16, 2021. F2 · derivative.exercise_date: The option vested as to 25% of the shares on March 1, 2019. The remainder of the shares vest in 36 substantially equal monthly installments thereafter. Read SEC document |
| November 03, 2021 Filed Nov 4, 2021 16:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 1,000 | $154.25 | $154,250.00 |
DisclosureSEC source: 0001179110-21-009878 · edgar.xml · nonDerivative · entry 2 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,278 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on August 16, 2021. Read SEC document |
| November 03, 2021 Filed Nov 4, 2021 16:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,000 | $38.55 | $38,550.00 |
DisclosureSEC source: 0001179110-21-009878 · edgar.xml · nonDerivative · entry 1 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,278 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on August 16, 2021. Read SEC document |
| March 05, 2021 Filed Mar 9, 2021 17:53 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 4,463 | $183.18 | $817,550.19 |
DisclosureSEC source: 0001179110-21-003160 · edgar.xml · nonDerivative · entry 1 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,278 F1 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit and performance stock unit awards. Read SEC document |
| March 04, 2021 Filed Mar 5, 2021 17:34 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 4,811 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-002996 · edgar.xml · derivative · entry 8 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,811 Underlying: Common Stock · 4,811 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F7 · derivative.exercise_date: On February 26, 2020, the reporting person earned 14,433 performance stock units, vesting in three substantially equal annual installments beginning on March 4, 2020. The number of performance stock units earned has been decreased by one due to a rounding error on the reporting person's Form 4 that was filed on February 28, 2020. F7 · derivative.expiration_date: On February 26, 2020, the reporting person earned 14,433 performance stock units, vesting in three substantially equal annual installments beginning on March 4, 2020. The number of performance stock units earned has been decreased by one due to a rounding error on the reporting person's Form 4 that was filed on February 28, 2020. F7 · balance_after: On February 26, 2020, the reporting person earned 14,433 performance stock units, vesting in three substantially equal annual installments beginning on March 4, 2020. The number of performance stock units earned has been decreased by one due to a rounding error on the reporting person's Form 4 that was filed on February 28, 2020. Read SEC document |
| March 04, 2021 Filed Mar 5, 2021 17:34 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 3,701 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-002996 · edgar.xml · derivative · entry 7 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,701 Underlying: Common Stock · 3,701 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F6 · derivative.exercise_date: On March 4, 2019, the reporting person was granted 11,103 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. F6 · derivative.expiration_date: On March 4, 2019, the reporting person was granted 11,103 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| March 04, 2021 Filed Mar 5, 2021 17:34 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 4,811 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-21-002996 · edgar.xml · nonDerivative · entry 5 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,741 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 04, 2021 Filed Mar 5, 2021 17:34 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 3,701 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-21-002996 · edgar.xml · nonDerivative · entry 4 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,930 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 04, 2021 Filed Mar 5, 2021 17:34 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 956 | $200.48 | $191,654.10 |
DisclosureSEC source: 0001179110-21-002996 · edgar.xml · nonDerivative · entry 3 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,229 F4 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 17:34 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 1,925 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-002996 · edgar.xml · derivative · entry 6 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,925 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F3 · derivative.exercise_date: On May 25, 2017, the reporting person was granted 7,700 restricted stock units, vesting in four substantially equal annual installments beginning on March 3, 2018. F3 · derivative.expiration_date: On May 25, 2017, the reporting person was granted 7,700 restricted stock units, vesting in four substantially equal annual installments beginning on March 3, 2018. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 17:34 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,925 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-21-002996 · edgar.xml · nonDerivative · entry 2 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,185 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 17:34 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 2,517 | $206.99 | $520,993.83 |
DisclosureSEC source: 0001179110-21-002996 · edgar.xml · nonDerivative · entry 1 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,260 F1 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit and performance stock unit awards. Read SEC document |
| March 02, 2021 Filed Mar 3, 2021 20:16 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 3,442 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-002815 · edgar.xml · derivative · entry 14 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,442 Underlying: Common Stock · 3,442 shares Expires not disclosed F13 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F14 · derivative.exercise_date: The restricted stock units vest in three substantially equal annual installments beginning on the first anniversary of the grant date. F14 · derivative.expiration_date: The restricted stock units vest in three substantially equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| March 02, 2021 Filed Mar 3, 2021 20:16 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 3,072 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-002815 · edgar.xml · derivative · entry 13 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,146 Underlying: Common Stock · 3,072 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F12 · derivative.exercise_date: On March 2, 2021, the reporting person earned 9,218 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2021. F12 · derivative.expiration_date: On March 2, 2021, the reporting person earned 9,218 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2021. Read SEC document |
| March 02, 2021 Filed Mar 3, 2021 20:16 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantPerformance Stock Units · Derivative | 9,218 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-002815 · edgar.xml · derivative · entry 12 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,218 Underlying: Common Stock · 9,218 shares Expires not disclosed F9 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of TDOC common stock. F10 · shares: Performance award amount determined based on metrics in respect of the issuer's 2020 financial results. F11 · derivative.exercise_date: The performance stock units vest in three substantially equal annual installments beginning on March 2, 2021. F11 · derivative.expiration_date: The performance stock units vest in three substantially equal annual installments beginning on March 2, 2021. Read SEC document |
| March 02, 2021 Filed Mar 3, 2021 20:16 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 1,807 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-002815 · edgar.xml · derivative · entry 11 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,615 Underlying: Common Stock · 1,807 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F8 · derivative.exercise_date: On March 2, 2020, the reporting person was granted 5,422 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. F8 · derivative.expiration_date: On March 2, 2020, the reporting person was granted 5,422 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| March 02, 2021 Filed Mar 3, 2021 20:16 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 3,072 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-21-002815 · edgar.xml · nonDerivative · entry 7 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,777 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 02, 2021 Filed Mar 3, 2021 20:16 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,807 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-21-002815 · edgar.xml · nonDerivative · entry 6 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,705 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 02, 2021 Filed Mar 3, 2021 20:16 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 1,547 | $224.28 | $346,964.25 |
DisclosureSEC source: 0001179110-21-002815 · edgar.xml · nonDerivative · entry 5 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,898 F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 20:16 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 969 | $0.00 Strike: $38.55 | $0.00 |
DisclosureSEC source: 0001179110-21-002815 · edgar.xml · derivative · entry 10 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,331 Underlying: Common Stock · 969 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 4, 2020. F7 · derivative.exercise_date: The option vested as to 25% of the shares on March 1, 2019. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 20:16 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 6,031 | $0.00 Strike: $22.30 | $0.00 |
DisclosureSEC source: 0001179110-21-002815 · edgar.xml · derivative · entry 9 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,569 Underlying: Common Stock · 6,031 shares Expires 2027-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 4, 2020. F6 · derivative.exercise_date: The option vested as to 25% of the shares on March 3, 2018. The remainder of the shares vested in 36 equal monthly installments thereafter. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 20:16 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 3,169 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-002815 · edgar.xml · derivative · entry 8 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,169 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F5 · derivative.exercise_date: On March 1, 2018, the reporting person was granted 9,507 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. F5 · derivative.expiration_date: On March 1, 2018, the reporting person was granted 9,507 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 20:16 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 7,000 | $227.00 | $1,589,000.00 |
DisclosureSEC source: 0001179110-21-002815 · edgar.xml · nonDerivative · entry 4 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,445 F2 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 4, 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.